Research and Markets (http://www.researchandmarkets.com/research/tz2c98/metastatic_breast)
has announced the addition of the "Metastatic
Breast Cancer - Pipeline Review, H1 2014" report to their
This report provides comprehensive information on the therapeutic
development for Metastatic Breast Cancer, complete with comparative
analysis at various stages, therapeutics assessment by drug target,
mechanism of action (MoA), route of administration (RoA) and molecule
type, along with latest updates, and featured news and press releases.
It also reviews key players involved in the therapeutic development for
Metastatic Breast Cancer and special features on late-stage and
and much more...
For more information visit http://www.researchandmarkets.com/research/tz2c98/metastatic_breast
[ Back To NFVZone's Homepage ]